Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma.
Bartsch G, Eggert K, Soker S, Bokemeyer C, Hautmann R, Schuch G. Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma. J Urol. 2008 Jan; 179(1):326-32.